Hier beginnt der Kopfbereich - Meta-Navigation und Logos

Kein Link zur Sprachversion EN EN

Hier beginnt die Unternavigation für den Bereich

Ihr Ausdruck wurde in der folgenden Navigationsebene erstellt:

Hier beginnt der Inhaltsbereich
Herzlich willkommen im Portal für unsere Kollegen und Partner in der Medizin!
Visual Content 1
Visual Content 2



D.J. Perkins, P.G. Kremsner, J.B. Weinberg:Inverse relationship of plasma prostaglandin E2 and blood mononuclear cell cyclooxygenase-2 with disease severity in children with Plasmodium falciparum malaria.Journal of Infectious Diseases 183: 113-118 (2001)


J. May, B. Lell, A.J.F. Luty, C.G. Meyer, P.G. Kremsner:HLA-DQB1*0501-restricted Th1 type immune responses to Plasmodium falciparum liver stage antigen 1 protect against malaria anemia and reinfections.Journal of Infectious Diseases 183: 168-172 (2001)


C. Lindenthal, E.A. Elsinghorst:Enteroxigenic Escherichia coli TibA glycoprotein adheres to human intestine epithelial cells.Infection and Immunity 69: 52-57 (2001)


A. Schwenke, C. Brandts, J. Philipps, S. Winkler, W.H. Wernsdorfer, P.G. Kremsner:Declining chloroquine resistance of Plasmodium falciparum in Lambarene, Gabon from 1992 to 1998.Wiener Klinische Wochenschrift 113: 63-64 (2001)


A. Draube, R. Pfister, M. Vockerodt, S. Schuster, D. Kube, V. Diehl, H. Tesch:Immunomagnetic enrichment of CD138 positive cells from weakly infiltrated myeloma patients samples enables the determination of the tumor clone specific IgH rearrangemenent.Annals of Hematology 80: 83-89 (2001)


M. Vockerodt, B. Haier, P. Buttgereit, H. Tesch, D. Kube:The Epstein-Barr virus latent membrane protein 1 induces interleukin-10 in Burkitt's lymphoma cells but not in Hodgkin's cells involving the p38/SAPK2 pathway.Virology 280: 183-198 (2001)


B. Lell, M. Sovric, D. Schmid, D. Luckner, K. Herbich, H. Long, W. Graninger, P.G. Kremsner:Effect of antipyretic drugs in children with malaria.Clinical Infectious Diseases 32: 838-841 (2001)


H.J. Schluesener, P.G. Kremsner, R. Meyermann:Heme oxygenase-1 in lesions of human cerebral malaria.Acta Neuropathologica 101: 65-68 (2001)


J.D. Kurtis, M.R. Hollingdale, A.J.F. Luty, D.E. Lanar, U. Krzych, P.E. Duffy:Pre-erythrocytic immunity to Plasmodium falciparum: the case for an LSA-1 vaccine.Trends in Parasitology 17: 219-223 (2001)


B. Lell, R. Viehbahn, P.G. Kremsner:The activity of ozone against Plasmodium falciparum.Ozone Science and Engineering 23: 89-93 (2001)


V. Poaty-Mavoungou, R. Onanga, P. Yaba, A. Delicat, G. Dubreuil, E. Mavoungou:Comparative analysis of natural killer cell analysis, lymphoproliferation and lymphocyte surface antigen expression in nonhuman primates housed at the CIRMF primate center, Gabon.Journal of Medical Primatology 30: 26-35 (2001)


R.H. Binks, J. Baum, A.M.J. Oduola, D.E. Arnot, H.A. Babiker, P.G. Kremsner, C. Roper, B.M. Greenwood, D.J. Conway:Population genetic analysis of the Plasmodium falciparum erythrocyte binding antigen-175 (eba-175) gene.Molecular and Biochemical Parasitology 114: 63-70 (2001)


V. Poaty-Mavoungou, R. Onanga, I. Bedjabaga, E. Mavoungou:Simian immunodeficiency virus from mandrill (Mandrillus sphinx) SIVmnd experimentally infects human and nonhuman primate cells.Microbes and Infection 3: 1-12 (2001)


E.H.K. Sylla, B. Lell, J.F.J. Kun, P.G. Kremsner:Plasmodium falciparum transmission intensity and infection rates in children in Gabon.Parasitology Research 87: 530-533 (2001)


H.Y. Long, B. Lell, K. Dietz, P.G. Kremsner:Plasmodium falciparum: in vitro growth inhibition by febrile temperatures.Parasitology Research 87: 553-555 (2001)


D. Kube, M. Vockerodt:Transient gene expression and MACS enrichment.Methods in Molecular Biology 174: 155-164 (2001)


D. Kube, U. Holtick, M. Vockerodt, T. Ahmadi, B. Haier, I. Behrmann, P.C. Heinrich, V. Diehl, H. Tesch:STAT3 is constitutively activated in Hodgkin cell lines.Blood 98: 762-770 (2001)


A. Tebo, P.G. Kremsner, A.J.F. Luty:Plasmodium falciparum: A major role for IgG3 in antibody-dependent monocyte-mediated cellular inhibition of parasite growth in vitro.Experimental Parasitology 98: 20-28 (2001)


J.F.J. Kun, B. Mordmüller, D.J. Perkins, J. May, O. Mercereau-Puijalon, M. Alpers, J.B. Weinberg, P.G. Kremsner:Nitric oxide synthase 2Lambarene (G-954C), increased nitric oxide production, and protection against malaria.Journal of Infectious Diseases 184: 330-336 (2001)


D. Kube, H. Rieth, J. Eskdale, P.G. Kremsner, G. Gallagher:Structural characterization of the distal 5' flanking region of the human interleukin-10 gene.Genes and Immunity 2: 181-190 (2001)


D.P. Mawili-Mboumba, M.T. Ekala, F. Lekoulou, F. Ntoumi:Molecular analysis of DHFR and DHPS genes in P. falciparum clinical isolates from the Haut-Ogooue region in Gabon.Acta Tropica 78: 231-240 (2001)


D. Kube, D. Schmidt, M. Mörmann, A.C. Uhlemann, J. Tomiuk, H. Tesch, P.G. Kremsner:Semiautomated and simultaneous analysis of the interleukin-10 gene microsatellites IL-10G and IL-10R by fluorescence-based polymerase chain reaction reveals significant differences in allelle distributions between Caucasians (Germany) and Africans (Gabon).European Cytokine Network 12: 537-544 (2001)


S. Borrmann, N. Szlezak, J.F. Faucher, P.B. Matsiegui, R. Neubauer, R. Binder, B. Lell, P.G. Kremsner:Artesunate and praziquantel for the treatment of Schistosoma haematobium infections: a double blind, randomized, placebo-controlled study.Journal of Infectious Diseases 184: 1363-1366 (2001)


A.C. Uhlemann, R.M. Oguariri, D.J. McColl, R.L. Coppel, P.G. Kremsner, R.F. Anders, J.F.J. Kun:Properties of the Plasmodium falciparum homologue of a protective vaccine candidate of Plasmodium yoelii.Molecular and Biochemical Parasitology 118: 41-48 (2001)


R.M. Oguariri, S. Borrmann, M.Q. Klinkert, P.G. Kremsner, J.F.J. Kun:High prevalence of human antibodies to recombinant duffy binding-like alpha domains of the Plasmodium falciparum-infected erythrocyte membrane protein 1 in semi-immune adults compared to that in nonimmune children.Infection and Immunity 69: 7603-7609 (2001)


M.A. Missinou, J.F.J. Kun, B. Lell, P.G. Kremsner:Change in Plasmodium falciparum genotype during successive malaria episodes in Gabonese children.Parasitology Research 87: 1020-1023 (2001)


A. Wilfing, S. Winkler, K. Schrattbauer, M. Willheim, K. Bauer, A. Aichelburg, T. Müller, W. Graninger, P.G. Kremsner:African-European differences in the capacity of T-cell cytokine production.American Journal of Tropical Medicine and Hygiene 65: 504-509 (2001)


T. Planche, S. Krishna, M. Kombila, K. Engel, J.F. Faucher, E. Ngou-Milama, P.G. Kremsner:Comparison of methods for the rapid laboratory assessment of children with malaria.American Journal of Tropical Medicine and Hygiene 65: 599-602 (2001)


M.P. Grobusch, K. Göbels, D. Teichmann, F. Bergmann, N. Suttorp:Early-stage elephantiasis in Bancroftian filariasis.European Journal of Clinical Microbiology and Infectious Diseases 20: 835-836 (2001)


B. Lell, S. Borrmann, M. Yazdanbakhsh, P.G. Kremsner:Atopy and malaria.Wiener Klinische Wochenschrift 113: 927-929 (2001)


A.H. van den Biggelaer, C. Lopuhaa, R. van Ree, J.S. van der Zee, J. Jans, A. Hoek, B. Migombet, S. Borrmann, D. Luckner, P.G. Kremsner, M. Yazdanbakhsh:The prevalence of parasite infestation and house dust mite sensitization in Gabonese schoolchildren.International Archives of Allergy and Immunology 126: 231-238 (2001)


A.J.F. Luty, M. Bongartz, P. Rezbach, J.F. Faucher, M.R. Hollingdale, P.G. Kremsner:Plasmodium falciparum liver stage antigen-1 peptide-specific interferon-gamma responses are not suppressed during uncomplicated malaria in African children.European Cytokine Network 12: 647-653 (2001)


F. Migot-Nabias, A.J.F. Luty, T.N. Minh, I. Fajardy, G.R.Tamouza, F. Marzais, D. Charron, P.M. Danze, A. Renaut, P. Deloron:HLA alleles in relation to specific immunity to liver stage antigen-1 from Plasmodium falciparum in Gabon.Genes and Immunity 2: 4-10 (2001)


F. Ntoumi, J. Ngoundou-Landji, A. Luty, G. Dubreuil, P. Millet:Polymorphisme allellique du gene MSP-2 de Plasmodium falciparum analyse a partir d'echantillons sanguins d'enfants gabonais. Bulletin de la Societe de Pathologie Exotique 94: 183-187 (2001)


S. Issifou, S. Ndjikou, A. Sanni, F. Lekoulou, F. Ntoumi:Pas d'influence de la saison de transmission ni de l'age des patients sur la complexite et la diversite genetique des infections a Plasmodium falciparum au Benin.Bulletin de la Societe de Pathologie Exotique 94: 195-198 (2001)


E.M. Leroy, S. Baize, P. Debre, J. Landsoud-Soukate, E. Mavoungou:Early immune responses accompanying human asymptomatic Ebola infections.Clinical and Experimental Immunology 124: 453-460 (2001)


F.S. Toure, E. Mavoungou, J.M. Ndong, P. Tshipamba, P. Deloron:Erythrocyte binding antigen (EBA-175) of Plasmodium falciparum: improved genotype determination by nested polymerase chain reaction.Tropical Medicine and International Health 6: 767-769 (2001)


M. Vockerodt, H. Tesch, D. Kube:Epstein-Barr virus latent membrane protein-1 activates CD25 expression in lymphoma cells involving NFkappaB pathway.Genes and Immunity 2: 433-441 (2001)


A. Khattab, J. Kun, P. Deloron, P.G. Kremsner, M.Q. Klinkert:Variants of Plasmodium falciparum erythrocyte membrane protein 1 expressed by different placental parasites are closely related and adhere to chondroitin sulfate A.Journal of Infectious Diseases 183: 1165-1169 (2001)






Hier beginnt die Marginalspalte Suche und verschieden Module

Hier beginnt die Fusszeile - Impressum und Datenschutz
Cookie Einstellungen
Bitte treffen Sie eine Auswahl um fortzufahren.
Weitere Informationen zu den Auswirkungen Ihrer Auswahl finden Sie unter HILFE.
Um fortfahren zu können, müssen Sie eine Cookie-Auswahl treffen.

Cookies zulassen:
Wir setzen Analysetools (Google Analytics, Matomo) ein, um Besucher-Informationen wie z.B. Browser, Land, oder die Dauer, wie lange ein Benutzer auf unserer Seite verweilt, zu messen. Ihre IP-Adresse wird anonymisiert übertragen, die Verbindung zu Google ist verschlüsselt.

Nur notwendige Cookies zulassen:
Wir verzichten auf den Einsatz von Analysetools. Es werden jedoch technisch notwendige Cookies, die eine reibungslose Navigation und Nutzung der Webseite ermöglichen, gesetzt (beispielsweise den Zugang zum zugangsbeschränkten Bereich erlauben).

Sie können Ihre Cookie-Einstellung jederzeit auf der Seite Datenschutzerklärung ändern. Zum Impressum.


Cookies zulassen Nur notwendige Cookies zulassen